Alpha Teknova, Inc. (NASDAQ:TKNO – Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 644,600 shares, an increase of 83.3% from the December 31st total of 351,600 shares. Currently, 6.1% of the shares of the stock are short sold. Based on an average trading volume of 273,500 shares, the days-to-cover ratio is presently 2.4 days.
Institutional Trading of Alpha Teknova
A number of institutional investors have recently modified their holdings of TKNO. Roubaix Capital LLC acquired a new position in Alpha Teknova during the 3rd quarter worth approximately $2,015,000. Point72 Asset Management L.P. acquired a new stake in shares of Alpha Teknova during the 3rd quarter valued at approximately $1,483,000. State Street Corp raised its position in shares of Alpha Teknova by 249.3% during the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after acquiring an additional 54,700 shares in the last quarter. Geode Capital Management LLC grew its stake in Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock worth $911,000 after buying an additional 36,914 shares during the last quarter. Finally, Whalen Wealth Management Inc. bought a new position in Alpha Teknova during the 4th quarter worth $240,000. Hedge funds and other institutional investors own 13.81% of the company’s stock.
Alpha Teknova Price Performance
Alpha Teknova stock traded down $0.66 during midday trading on Friday, reaching $8.84. The company’s stock had a trading volume of 201,120 shares, compared to its average volume of 230,146. The firm has a market capitalization of $471.24 million, a PE ratio of -11.95 and a beta of 0.34. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. Alpha Teknova has a fifty-two week low of $1.15 and a fifty-two week high of $10.37. The stock’s 50 day simple moving average is $8.20 and its 200 day simple moving average is $6.10.
Alpha Teknova Company Profile
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Featured Articles
- Five stocks we like better than Alpha Teknova
- How to Plot Fibonacci Price Inflection Levels
- Nebius Group: Market Overreaction or Real AI Disruption?
- Retail Stocks Investing, Explained
- The Best Way to Invest in Gold Is…
- About the Markup Calculator
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.